N3661 - Exam 2 (Med Surg - D. Cleary) Exam
Questions With Correct Answers
Drug ||and ||food ||additives ||that ||are ||risk ||factors ||for ||developing ||asthma ||and ||status ||
asthmaticus ||(6)
aspirin ||(ASA: ||acetylsalicylic ||acid)
NSAIDs
beta ||blockers
ACE ||inhibitors
yellow ||dye ||#5
sulfiting ||agents ||in ||wine ||& ||beer
What ||are ||typical ||respiratory ||rate ||for ||someone ||having ||an ||asthma ||attack?
Pulse?
RR ||> ||30
HR ||>120
(think; ||trying ||to ||get ||air ||in ||and ||trying ||to ||push ||any ||oxygenated ||blood ||around ||body)
Cholelithiasis ||can ||interfere ||with ||absorption ||of ||what ||vitamins? ||(4)
vit ||A, ||D, ||E, ||K
Which ||of ||the ||following ||is ||likely ||to ||present ||diagnosis ||of ||fluid ||volume ||deficit?
a. ||appendicitis
b. ||pancreatitis
c. ||cholecystitis
d. ||peptic ||ulcer
b. ||pancreatitis
hypovolemia ||is ||typical ||because ||loss ||of ||protein-rich ||fluids ||into ||the ||tissues ||and ||peritoneal ||
cavity
(a, ||c, ||& ||d ||exhibit ||FV ||excess)
What ||are ||the ||classifications ||of ||asthma?
How ||often ||do ||symptoms ||occur?
,intermittent: ||<2 ||days/wk
persistent-mild: ||>2 ||days/wk ||(not ||daily)
persistent-moderate: ||daily
persistent-severe: ||continuous ||symptoms
Define ||FEV1
forced ||expiratory ||volume ||in ||1 ||second
(vital ||capacity ||= ||maximum ||inspiration ||& ||expiration ||volume)
(FEV1 ||= ||how ||much ||of ||your ||inhale ||can ||you ||force ||out ||in ||1 ||second, ||typically ||80%)
(FEV3 ||= ||almost ||100% ||of ||vital ||capacity ||exhaled ||forcefully)
For ||the ||asthma ||categories, ||what ||are ||the ||expected ||FEV1?
intermittent: ||normal ||FEV1 ||(about ||80%)
persistent-mild: ||FEV1 ||> ||80% ||predicted ||(80% ||of ||typical ||80%)
persistent-moderate: ||FEV1 ||= ||60-80% ||predicted
persistent-severe: ||FEV1 ||< ||80% ||predicted
Which ||classifications ||of ||asthma ||will ||experience ||nighttime ||symptoms? ||How ||often?
persistent-moderate: ||>1/wk
persistent-severe: ||often
In ||regards ||to ||asthma, ||what ||does ||SABA ||mean?
short-acting ||beta ||2 ||adrenergic ||agonists ||(albuterol, ||levalbuterol, ||pirbuterol)
aka ||quick-relief ||medications
Which ||classifications ||of ||asthma ||would ||you ||expect ||frequent ||use ||of ||SABAs? ||How ||often?
(albuterol, ||levalbuterol, ||pirbuterol)
persistent-moderate: ||daily
persistent-severe: ||several ||times ||daily
SABA ||medications ||(3)
albuterol
levalbuterol
pirbuterol
What ||drug ||classification ||are ||used ||for ||quick ||asthma ||relief?
, bronchodilators: ||SABA ||and ||anticholinergics ||(ipratropium)
anti-inflammatories: ||corticosteroids ||(systemic)
What ||anticholinergic ||medication ||is ||commonly ||used ||for ||asthma ||relief?
What ||type ||of ||relief: ||quick ||or ||long-acting?
ipratropium ||
quick ||relief
What ||corticosteroid ||medications ||are ||commonly ||used ||for ||asthma ||relief?
What ||type ||of ||relief: ||quick ||or ||long-acting?
both ||quick ||and ||long-acting
methylprednisolone
prednisolone
prednisone
budesonide ||(inhaled ||for ||long-term ||tx)
endings: ||-sone, ||-lone, ||-nide, ||-lide
Which ||asthmatic ||medication ||classification ||can ||be ||of ||concern ||for ||a ||diabetic ||patient? ||
Why?
corticosteroids ||(prednisone, ||prednisolone, ||methylprednisolone, ||budesonide)
increase ||blood ||glucose ||levels ||by ||reducing ||action ||of ||insulin ||and ||encourages ||liver ||to ||
release ||stored ||glucose
What ||drug ||classifications ||are ||used ||for ||long ||term ||asthma ||control?
anti-inflammatory ||drugs: ||corticosteroids ||(inhaled ||& ||systemic), ||leukotriene ||modifiers, ||anti-
IgE
bronchodilators: ||LABA ||(oral ||albuterol ||& ||inhaled: ||salmeterol/formoterol), ||methylxanthines ||
(rarely ||used)
What ||leukotriene ||modifier ||medications ||are ||commonly ||used ||for ||asthma ||relief?
What ||type ||of ||relief: ||quick ||or ||long-acting?
long ||acting
montelukast ||(Singular)
zafirlukast
Questions With Correct Answers
Drug ||and ||food ||additives ||that ||are ||risk ||factors ||for ||developing ||asthma ||and ||status ||
asthmaticus ||(6)
aspirin ||(ASA: ||acetylsalicylic ||acid)
NSAIDs
beta ||blockers
ACE ||inhibitors
yellow ||dye ||#5
sulfiting ||agents ||in ||wine ||& ||beer
What ||are ||typical ||respiratory ||rate ||for ||someone ||having ||an ||asthma ||attack?
Pulse?
RR ||> ||30
HR ||>120
(think; ||trying ||to ||get ||air ||in ||and ||trying ||to ||push ||any ||oxygenated ||blood ||around ||body)
Cholelithiasis ||can ||interfere ||with ||absorption ||of ||what ||vitamins? ||(4)
vit ||A, ||D, ||E, ||K
Which ||of ||the ||following ||is ||likely ||to ||present ||diagnosis ||of ||fluid ||volume ||deficit?
a. ||appendicitis
b. ||pancreatitis
c. ||cholecystitis
d. ||peptic ||ulcer
b. ||pancreatitis
hypovolemia ||is ||typical ||because ||loss ||of ||protein-rich ||fluids ||into ||the ||tissues ||and ||peritoneal ||
cavity
(a, ||c, ||& ||d ||exhibit ||FV ||excess)
What ||are ||the ||classifications ||of ||asthma?
How ||often ||do ||symptoms ||occur?
,intermittent: ||<2 ||days/wk
persistent-mild: ||>2 ||days/wk ||(not ||daily)
persistent-moderate: ||daily
persistent-severe: ||continuous ||symptoms
Define ||FEV1
forced ||expiratory ||volume ||in ||1 ||second
(vital ||capacity ||= ||maximum ||inspiration ||& ||expiration ||volume)
(FEV1 ||= ||how ||much ||of ||your ||inhale ||can ||you ||force ||out ||in ||1 ||second, ||typically ||80%)
(FEV3 ||= ||almost ||100% ||of ||vital ||capacity ||exhaled ||forcefully)
For ||the ||asthma ||categories, ||what ||are ||the ||expected ||FEV1?
intermittent: ||normal ||FEV1 ||(about ||80%)
persistent-mild: ||FEV1 ||> ||80% ||predicted ||(80% ||of ||typical ||80%)
persistent-moderate: ||FEV1 ||= ||60-80% ||predicted
persistent-severe: ||FEV1 ||< ||80% ||predicted
Which ||classifications ||of ||asthma ||will ||experience ||nighttime ||symptoms? ||How ||often?
persistent-moderate: ||>1/wk
persistent-severe: ||often
In ||regards ||to ||asthma, ||what ||does ||SABA ||mean?
short-acting ||beta ||2 ||adrenergic ||agonists ||(albuterol, ||levalbuterol, ||pirbuterol)
aka ||quick-relief ||medications
Which ||classifications ||of ||asthma ||would ||you ||expect ||frequent ||use ||of ||SABAs? ||How ||often?
(albuterol, ||levalbuterol, ||pirbuterol)
persistent-moderate: ||daily
persistent-severe: ||several ||times ||daily
SABA ||medications ||(3)
albuterol
levalbuterol
pirbuterol
What ||drug ||classification ||are ||used ||for ||quick ||asthma ||relief?
, bronchodilators: ||SABA ||and ||anticholinergics ||(ipratropium)
anti-inflammatories: ||corticosteroids ||(systemic)
What ||anticholinergic ||medication ||is ||commonly ||used ||for ||asthma ||relief?
What ||type ||of ||relief: ||quick ||or ||long-acting?
ipratropium ||
quick ||relief
What ||corticosteroid ||medications ||are ||commonly ||used ||for ||asthma ||relief?
What ||type ||of ||relief: ||quick ||or ||long-acting?
both ||quick ||and ||long-acting
methylprednisolone
prednisolone
prednisone
budesonide ||(inhaled ||for ||long-term ||tx)
endings: ||-sone, ||-lone, ||-nide, ||-lide
Which ||asthmatic ||medication ||classification ||can ||be ||of ||concern ||for ||a ||diabetic ||patient? ||
Why?
corticosteroids ||(prednisone, ||prednisolone, ||methylprednisolone, ||budesonide)
increase ||blood ||glucose ||levels ||by ||reducing ||action ||of ||insulin ||and ||encourages ||liver ||to ||
release ||stored ||glucose
What ||drug ||classifications ||are ||used ||for ||long ||term ||asthma ||control?
anti-inflammatory ||drugs: ||corticosteroids ||(inhaled ||& ||systemic), ||leukotriene ||modifiers, ||anti-
IgE
bronchodilators: ||LABA ||(oral ||albuterol ||& ||inhaled: ||salmeterol/formoterol), ||methylxanthines ||
(rarely ||used)
What ||leukotriene ||modifier ||medications ||are ||commonly ||used ||for ||asthma ||relief?
What ||type ||of ||relief: ||quick ||or ||long-acting?
long ||acting
montelukast ||(Singular)
zafirlukast
